The analysis revealed a significant association between elevated CHEK1 expression and unfavorable prognosis in patients with pancreatic cancer (Fig 2A, p = 0.00523; Fig 2B,p < 0.0001). Here, CHEK1 is linked to familial pancreatic carcinoma.